Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

Xuechao Liu,1,2,* Pengfei Xu,1,3,* Haibo Qiu,1,2,* Jianjun Liu,1,2 Shangxiang Chen,1,2 Dazhi Xu,1,2 Wei Li,1,2 Youqing Zhan,1,2 Yuanfang Li,1,2 Yingbo Chen,1,2 Zhiwei Zhou,1,2 Xiaowei Sun1,2 1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innova...

Full description

Bibliographic Details
Main Authors: Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:OncoTargets and Therapy
Subjects:
gastric cancer
HER2
immunohistochemistry
prognosis
adjuvant chemotherapy
Online Access:https://www.dovepress.com/clinical-utility-of-her2-assessed-by-immunohistochemistry-in-patients--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-utility-of-her2-assessed-by-immunohistochemistry-in-patients--peer-reviewed-article-OTT

Similar Items